Published in the March 31 advance online issue of Cell, their
findings reveal that circular RNAs — like their protein counterparts — are also affected by genomic rearrangements in cancer, resulting in
abnormal fusions.
These metabolites can be used for both diagnostic and therapeutic measurements for: detecting
abnormal gastrointestinal overgrowth or dysbiosis, assessing mitochondrial energy production, detecting genetic diseases, assessing malnutrition and suboptimum nutrition,
revealing toxic exposure,
finding alterations of neurotransmitter metabolites in neurological and psychiatric disorders, and assessing metabolites that cause severe inflammation in a variety of chronic illnesses.